The estimated Net Worth of Kevin Schuyler is at least $0 dollars as of 29 September 2023. Kevin Schuyler owns over 700 units of Adial Pharmaceuticals, WT EXP 073123 stock worth over $0 and over the last 6 years Kevin sold ADILW stock worth over $0.
Sign up
Kevin Schuyler ADILW stock SEC Form 4 insiders trading
Kevin has made over 2 trades of the Adial Pharmaceuticals, WT EXP 073123 stock since 2018, according to the Form 4 filled with the SEC. Most recently Kevin bought 700 units of ADILW stock worth $1,918 on 29 September 2023.
The largest trade Kevin's ever made was buying 90,000 units of Adial Pharmaceuticals, WT EXP 073123 stock on 31 July 2018 worth over $0. On average, Kevin trades about 9,070 units every 189 days since 2018. As of 29 September 2023 Kevin still owns at least 700 units of Adial Pharmaceuticals, WT EXP 073123 stock.
You can see the complete history of Kevin Schuyler stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Kevin Schuyler's mailing address?
Kevin's mailing address filed with the SEC is 4870 SADLER ROAD, STE 300, , GLEN ALLEN,, VA, 23060.
Insiders trading at Adial Pharmaceuticals, WT EXP 073123
Over the last 6 years, insiders at Adial Pharmaceuticals, WT EXP 073123 have traded over $948,500 worth of Adial Pharmaceuticals, WT EXP 073123 stock and bought 344,044 units worth $452,385 . The most active insiders traders include Bankole A. Johnson, William B. Iii Stilley y Kevin Schuyler. On average, Adial Pharmaceuticals, WT EXP 073123 executives and independent directors trade stock every 145 days with the average trade being worth of $0. The most recent stock trade was executed by Kevin Schuyler on 29 September 2023, trading 700 units of ADILW stock currently worth $1,918.
What does Adial Pharmaceuticals, WT EXP 073123's logo look like?
Complete history of Kevin Schuyler stock trades at Adial Pharmaceuticals, WT EXP 073123
Adial Pharmaceuticals, WT EXP 073123 executives and stock owners
Adial Pharmaceuticals, WT EXP 073123 executives and other stock owners filed with the SEC include:
-
James W. Jr. Newman,
Director -
Joseph Truluck,
Chief Financial Officer -
Bankole A. Johnson,
Director -
Robertson H. Gilliland,
Director -
Tony Goodman,
Chief Operating Officer -
J. Kermit Anderson,
Director -
Jack W Reich,
Director -
Kevin Schuyler,
Director -
William B. Iii Stilley,
Director -
Cary J Claiborne,
Chief Executive Officer